FDA approves new Alzheimer’s drug that appears to slow progression of disease
FDA approved new Alzheimer’s drug shown to slow cognitive decline in patients in the early stages of the illness.
FDA approved new Alzheimer’s drug shown to slow cognitive decline in patients in the early stages of the illness.